Intravitreal aflibercept in the treatment of polypoidal choroidal vasculopathy associated with morning glory syndrome

Conclusion: Polypoidal choroidal vasculopathy can occur in morning glory syndrome and it can be successfully treated with anti–vascular endothelial growth factor intravitreal injections of aflibercept.
Source: Retinal Cases and Brief Reports - Category: Opthalmology Tags: Case Report Source Type: research